Humanoid claims Europe's first pure-play unicorn at $1.35B
22 July 2026Liang — Editor, Compare Humanoids1 min de lecture

What happened
Fiche technique
Humanoid HMND 01
- Hauteur
- 220 cm
- Poids
- 300 kg
- Gamme de prix
- €40–100k
- EU-Ready
- 2.5/5
Voir les specs & la disponibilité UE →
Fiche technique
F&P Robotics Lio
- Hauteur
- —
- Poids
- —
- Gamme de prix
- €100k+
- EU-Ready
- Sur demande
Voir les specs & la disponibilité UE →
Fiche technique
Addverb Elixis
- Hauteur
- 175 cm
- Poids
- 75 kg
- Gamme de prix
- €100k+
- EU-Ready
- Sur demande
Voir les specs & la disponibilité UE →
UK-based AI and robotics company Humanoid announced a $152 million Series A financing round at a $1.35 billion post-money valuation. The investment was led by Prime Movers Lab, a venture capital firm focused on breakthrough scientific ventures, and brings the firm’s total capital raised to $270 million.
Humanoid is developing industrial humanoid robots, including the HMND 01 platform, and is publicly branding the deal as making it Europe’s first pure-play humanoid robotics unicorn. The source item does not detail product specifications, commercial release dates, manufacturing scale, or current customer deployments.
Why it matters for European buyers
For procurement teams on the continent, the funding round generates headline interest but offers little immediate operational clarity. The source confirms the company is headquartered in the United Kingdom, yet it provides no facts about EU distribution channels, continental warehousing, authorised representatives, or expected delivery timelines for the HMND 01. Buyers must therefore treat claims of European market leadership as a positioning statement rather than proof of local supply-chain readiness. The item is also silent on regulatory compliance: there is no mention of CE marking, EU machinery-safety documentation, risk assessments, or conformity procedures, which are mandatory for placing industrial robots into service within the single market. On the financial side, the announcement gives no price bands, lease structures, subscription models, or total-cost-of-ownership benchmarks, meaning the $152 million raise and $1.35 billion valuation signal deep investor appetite but give procurement departments no quantitative basis for budget planning or vendor comparison. Until Humanoid releases concrete EU-specific availability, compliance certifications, and pricing, European industrial buyers should view this milestone as a capital-markets event rather than a green light for procurement.